Marrone Bio Innovations and Informa to Host Webinar on Spotted Wing Drosophila Integrated Pest Management

DAVIS, Calif., June 5, 2015 (GLOBE NEWSWIRE) — Marrone Bio Innovations, Inc. (MBI), (Nasdaq:MBII), a leading provider of bio-based pest management and plant health products for the agriculture, turf and ornamental and water treatment markets, and in association with Informa’s Crops and Chemicals USA event, the global information specialist for the food and agricultural supply chain, today announced that they will host a free webinar on the topic of Spotted Wing Drosophila Integrated Pest Management (IPM) on June 10th at 11:00 AM ET.

The webinar will be led by Dr. Tim Johnson, Product Development Manager for Marrone Bio Innovations. Other presenters include:

  • Dr. Hannah Burrack, Associate Professor of Entomology and Extension Specialist, North Carolina State University
  • Dr. Cesar Rodriguez-Saona, Associate Extension Specialist in Entomology, Rutgers University
  • Dr. Richard Cowles, Agricultural Scientist, Connecticut Agricultural Experiment Station

“Spotted Wing Drosophila is an invasive pest that is causing major problems in fruit and berry crops and it is spreading globally,” said MBI’sTim Johnson. “This webinar will provide a detailed summary of IPM management tactics  to control this invasive pest and protect fruit crops in both conventional and organic production.”

The webinar is available at no charge in association with Informa’s Crops and Chemicals USA event and can be accessed via the following link: https://attendee.gotowebinar.com/register/6506055859268469250

About Marrone Bio Innovations

Marrone Bio Innovations, Inc. (Nasdaq:MBII) is a leading provider of bio-based pest management and plant health products for the agriculture, turf and ornamental and water treatment markets. Our effective and environmentally responsible solutions help customers operate more sustainably while controlling pests, improving plant health, and increasing crop yields. We have a proprietary discovery process, a rapid development platform, and a robust pipeline of pest management and plant health product candidates. At Marrone Bio Innovations we are dedicated to pioneering better biopesticides that support a better tomorrow for users around the globe. For more information, please visitwww.marronebio.com.

Forward Looking Statements

Portions of this press release may constitute “forward-looking statements,” and assumptions underlying such forward-looking statements, within the meaning of the Private Securities Litigation Reform Act of 1995 (the “PSLRA”), Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. Any such forward-looking statements are made within the “safe-harbor” protections of the PSLRA, should not be relied upon as representing our views as of any subsequent date, and we are under no obligation to, and expressly disclaims any responsibility to, update or alter these forward-looking statements, whether as a result of new information, future events or otherwise. Forward-looking statements in this filing include those regarding implementing our business strategy, expectations regarding our sales team and driving sales of our products. Such forward-looking statements are based on information available to us as of the date of this release and involve a number of risks and uncertainties, some beyond our control, that could cause actual results to differ materially from those anticipated by these forward-looking statements. Such risks include adverse weather conditions and seasonality that may affect sales, failure of customers to adopt our products, the high level of competition in the market for pest management products, inability to maintain and further establish successful relationships with third-party distributors, the failure of our third-party distributors to sell to end users and uncertainty surrounding our compliance with our financial reporting obligations. Additional information that could lead to material changes in our performance is contained in our filings with the Securities and Exchange Commission.

CONTACT: Media Contact:
Cory Ziskind
ICR
646-277-1232
Cory.Ziskind@icrinc.com

Evogene CEO Ofer Haviv and Marrone Bio Innovations CEO Pam Marrone to Participate in ‘Profiling Tomorrow’s Ag Solutions’ Panel Discussion at AgriVest 2015

Companies to provide update on their multiyear collaboration for the discovery of new insect control solutions

Rehovot, Israel and Davis, California – April 27, 2015 – Evogene Ltd. (NYSE, TASE: EVGN), a leading company for the improvement of crop productivity and economics for the food, feed and biofuel industries, and Marrone Bio Innovations, Inc. (MBI), (NASDAQ: MBII), a leading provider of bio-based pest management and plant health products for the agriculture, turf and ornamental and water treatment markets, today announced their respective Chief Executive Officers,  Ofer Haviv and Pam Marrone, will participate in the ‘Profiling Tomorrow’s Ag Solutions’ panel discussion at AgriVest 2015, the Israeli Agritech Investment Event.

The panel discussion will take place on April 27th at 11:30 AM Israel Time in Wix Auditorium at the Weizmann Institute of Science, in Rehovot, Israel.  The panel will be moderated by Eyal Lipetz-Eliassi, Israel Country Manager & Innovation-Based Growth Leader, DuPont.  Additional panel members include Sam Fiorello, COO, Danforth Plant Science Center & President, Bio-Research & Development Growth Park; Barry J. Schindler, Co-Chair Global Patent Prosecution Group, GreenbergTraurig; and Alexander Wiegelmann, VP M&A/Head of Transactions, KWS SAAT AG.

Marrone will provide perspective on the role of bio-based pesticides in helping growers strengthen their integrated pest management programs, improve plant health, boost yields and increase profitability.  As part of the panel discussion, Evogene will provide insight on its strategic collaborations with some of the world’s leading agricultural companies, particularly in the area of improved seed traits development, as well as its more recent research and development efforts for novel crop protection solutions.

The two companies will also provide an update on their previously announced multiyear collaborative agreement targeting the joint discovery of novel modes of biological action for insect control, followed by the development and commercialization of new insect control products by each of the companies.

“The unique partnership with MBI has brought together two very unique capabilities in our industry today – MBI’s expertise in microbial-based solutions for pest control and plant health, and Evogene’s computational gene discovery capabilities,” said Ofer Haviv, President and CEO of Evogene. “Only a few months into the collaborative work plan, we have already completed the selection process, with the first set of candidate microbes showing high efficacy in testing. These microbial candidates will form the key targets for the upcoming gene discovery round which will be conducted utilizing Evogene’s proprietary computational platforms.”

“This is an exciting time for agtech as there is an explosion of innovation all along the food chain from farm to fork,” said Pam Marrone, CEO of Marrone Bio Innovations.  “Collaboration is critical to driving innovation and we are very pleased with the results of our partnership with Evogene.  We are making good progress towards developing novel modes of action for insect control as our collaboration is enabling us to leverage our discovery and development strategy to explore an even wider range of microbes with novel insecticidal genes.”

 -xxx-

About Evogene Ltd.:

Evogene (NYSE, TASE: EVGN) is a leading company for the improvement of crop productivity and economics for the food, feed and biofuel industries. The Company has strategic collaborations with world-leading agricultural companies to develop improved seed traits in relation to yield and a-biotic stress (such as tolerance to drought), and biotic stress (such as resistance to disease and nematodes), in key crops as corn, soybean, wheat and rice, and is also focused on the research and development of new products for crop protection (such as weed control). In addition, the Company has a wholly-owned subsidiary, Evofuel, developing seeds for second generation feedstock for biodiesel. For more information, please visit www.evogene.com.

About Marrone Bio Innovations

Marrone Bio Innovations, Inc. (NASDAQ: MBII) is a leading provider of bio-based pest management and plant health products for the agriculture, turf and ornamental and water treatment markets. Our effective and environmentally responsible solutions help customers operate more sustainably while controlling pests, improving plant health, and increasing crop yields. We have a proprietary discovery process, a rapid development platform, and a robust pipeline of pest management and plant health product candidates. At Marrone Bio Innovations we are dedicated to pioneering better biopesticides that support a better tomorrow for users around the globe. For more information, please visit www.marronebio.com.

Forward Looking Statements

Portions of this press release may constitute “forward-looking statements,” and assumptions underlying such forward-looking statements, within the meaning of the Private Securities Litigation Reform Act of 1995 (the “PSLRA”), Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. Any such forward-looking statements are made within the “safe-harbor” protections of the PSLRA, should not be relied upon as representing our views as of any subsequent date, and we are under no obligation to, and expressly disclaims any responsibility to, update or alter these forward-looking statements, whether as a result of new information, future events or otherwise. Forward-looking statements in this filing include those regarding implementing our business strategy, expectations regarding our sales team and driving sales of our products.  Such forward-looking statements are based on information available to us as of the date of this release and involve a number of risks and uncertainties, some beyond our control, that could cause actual results to differ materially from those anticipated by these forward-looking statements. Such risks include adverse weather conditions and seasonality that may affect sales, failure of customers to adopt our products, the high level of competition in the market for pest management products, inability to maintain and further establish successful relationships with third-party distributors, the failure of our third-party distributors to sell to end users and uncertainty surrounding our compliance with our financial reporting obligations. Additional information that could lead to material changes in our performance is contained in our filings with the Securities and Exchange Commission.

Media Contact:

Karen Mazor, Evogene
Director, Public and Investor Relations
T: +972-54-2288 039
karen.mazor@evogene.com

Cory Ziskind
ICR
646-277-1232
Cory.Ziskind@icrinc.com

Marrone Bio Innovations Announces Opening of New Greenhouse to Facilitate and Expand Research and Product Development Capacity

DAVIS, Calif., April 22, 2015 (GLOBE NEWSWIRE) — Marrone Bio Innovations, Inc. (MBI), (Nasdaq:MBII), a leading provider of bio-based pest management and plant health products for the agriculture, turf and ornamental and water treatment markets, today announced the opening of its new greenhouse to facilitate and expand its research and product development capacity.

The new greenhouse, located adjacent to MBI’s corporate headquarters at 1540 Drew Avenue in Davis, CA, is triple the size of the existing greenhouse on this site at 3,000 square feet, and features state of the art technology in environmental control. In addition, five grow rooms were built, each with enhanced controls for temperate, humidity and lighting.

Pam Marrone, Chief Executive Officer of Marrone Bio Innovations commented, “We are thrilled to announce the opening of our new greenhouse on Earth Day as it will play a key role in enabling execution of our research, product development and business strategy. MBI’s new greenhouse will significantly expand our capacity to enhance our existing products and develop new effective and environmentally responsible bio-based products that promote plant health and control unwanted pests in agriculture, while increasing crop yields and profitability for growers.”

About Marrone Bio Innovations

Marrone Bio Innovations, Inc. (Nasdaq:MBII) is a leading provider of bio-based pest management and plant health products for the agriculture, turf and ornamental and water treatment markets. Our effective and environmentally responsible solutions help customers operate more sustainably while controlling pests, improving plant health, and increasing crop yields. We have a proprietary discovery process, a rapid development platform, and a robust pipeline of pest management and plant health product candidates. At Marrone Bio Innovations we are dedicated to pioneering better biopesticides that support a better tomorrow for users around the globe. For more information, please visit www.marronebio.com.

Forward Looking Statements

Portions of this press release may constitute “forward-looking statements,” and assumptions underlying such forward-looking statements, within the meaning of the Private Securities Litigation Reform Act of 1995 (the “PSLRA”), Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. Any such forward-looking statements are made within the “safe-harbor” protections of the PSLRA, should not be relied upon as representing our views as of any subsequent date, and we are under no obligation to, and expressly disclaims any responsibility to, update or alter these forward-looking statements, whether as a result of new information, future events or otherwise. Forward-looking statements in this filing include those regarding implementing our business strategy, expectations regarding our sales team and driving sales of our products. Such forward-looking statements are based on information available to us as of the date of this release and involve a number of risks and uncertainties, some beyond our control, that could cause actual results to differ materially from those anticipated by these forward-looking statements. Such risks include adverse weather conditions and seasonality that may affect sales, failure of customers to adopt our products, the high level of competition in the market for pest management products, inability to maintain and further establish successful relationships with third-party distributors, the failure of our third-party distributors to sell to end users and uncertainty surrounding our compliance with our financial reporting obligations. Additional information that could lead to material changes in our performance is contained in our filings with the Securities and Exchange Commission.

Media Contact:

Cory Ziskind
ICR
646-277-1232

Marrone Bio Innovations Strengthens Sales Team With Regional Territory Managers

April 7, 2015, DAVIS, CA — Marrone Bio Innovations, Inc. (MBI), (NASDAQ: MBII), a leading provider of bio-based pest management and plant health products for the agriculture, turf and ornamental and water treatment markets, today announced the recent additions of several strategic hires to its sales team as regional territory managers.

“With our new sales territory managers in place, we believe that we are well-positioned to implement our business strategy,” said Pam Marrone, Chief Executive Officer of Marrone Bio Innovations.

“We are very pleased to welcome this talented group of seasoned industry veterans to bolster our sales team,” said James Iademarco, President & Chief Operating Officer, MBI.  “Our sales territory managers have extensive experience from diverse companies, and we expect that they will play an important role as the Company seeks to drive sales of its products.”

Brian Ahrens, MBI’s VP Sales adds, “This sales team not only brings unique perspective on how to position  biological pest management and plant health solutions to key customers, but they are very passionate about helping growers strengthen their integrated pest management programs,  boost yields and increase profitability.”

MBI welcomes the following territory managers:

Jim Colitas – Northeast/Michigan
Jim has held various positions throughout his 26 year career with present-day Bayer CropScience.  For the past 14 years, he has worked with ADAMA in various positions in Field Sales, including as Specialty Product Manager and National Account Manager. Jim graduated from the University of New Hampshire with a Bachelor of Science degree in Plant Science and currently resides in Macungie, PA.

Lori Epperson – Mid South
Lori has 20 years of sales and strategic business experience in the agriculture industry.  She served as a Sales Representative and Account Manager with DuPont in territories in South Dakota, Ohio, and Illinois.  Lori holds a Bachelor of Science and Masters in Labor and Human Resources from The Ohio State University and lives just south of Starkville, MS.

Curt Nelson – Coastal California
Curt has 20 years of industry experience with Western Farm Service, T-System Irrigations, AgraQuest and ADAMA. He has held various positions in PCA, including as a Field Specialist, District Sales Manager and Market Development Manager. Curt was born and raised in the Salinas Valley and lives in the Dos Palos area.  He is very active in 4-H with the community and is currently enrolled in California Coast University’s Business Management program.

Jorge Pacheco – Pacific Northwest
Jorge has 20 years of retail sales and crop management experience in the U.S. and Latin American markets.  Prior to relocating to the Pacific Northwest in 2005, he served as an Account Manager and Sales Leader with DuPont in Texas and Nebraska.  Jorge holds a Bachelor of Science in Agriculture Economics from Texas A&M University-Kingsville and lives near Portland in Camas, WA.

Eric Johnson – West Central
Eric has been professionally selling in the Agriculture and Turf industry for over 12 years, having previously worked with Compass Minerals, Precision Laboratories and Kalo, Inc.  He has worked with various multiple step channel distribution throughout the Midwest, focusing on a value-added approach.  Eric is a graduate of the University of Kansas with a Bachelor of Science degree in Personnel Administration.  Other than four years spent living in Phoenix, Eric has resided in the Kansas City Metro area for his adult life.

*****

About Marrone Bio Innovations

Marrone Bio Innovations, Inc. (NASDAQ: MBII) is a leading provider of bio-based pest management and plant health products for the agriculture, turf and ornamental and water treatment markets. Our effective and environmentally responsible solutions help customers operate more sustainably while controlling pests, improving plant health, and increasing crop yields. We have a proprietary discovery process, a rapid development platform, and a robust pipeline of pest management and plant health product candidates. At Marrone Bio Innovations we are dedicated to pioneering better biopesticides that support a better tomorrow for users around the globe. For more information, please visit www.marronebio.com.

Forward Looking Statements

Portions of this press release may constitute “forward-looking statements,” and assumptions underlying such forward-looking statements, within the meaning of the Private Securities Litigation Reform Act of 1995 (the “PSLRA”), Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. Any such forward-looking statements are made within the “safe-harbor” protections of the PSLRA, should not be relied upon as representing our views as of any subsequent date, and we are under no obligation to, and expressly disclaims any responsibility to, update or alter these forward-looking statements, whether as a result of new information, future events or otherwise. Forward-looking statements in this filing include those regarding implementing our business strategy, expectations regarding our sales team and driving sales of our products.  Such forward-looking statements are based on information available to us as of the date of this release and involve a number of risks and uncertainties, some beyond our control, that could cause actual results to differ materially from those anticipated by these forward-looking statements. Such risks include adverse weather conditions and seasonality that may affect sales, failure of customers to adopt our products, the high level of competition in the market for pest management products, inability to maintain and further establish successful relationships with third-party distributors, the failure of our third-party distributors to sell to end users and uncertainty surrounding our compliance with our financial reporting obligations. Additional information that could lead to material changes in our performance is contained in our filings with the Securities and Exchange Commission.

Marrone Bio Innovations Announces Completion of Audit Committee Investigation; Update on Financial Statement Review and Status of NASDAQ Continued Listing

DAVIS, California, February 4, 2015 — Marrone Bio Innovations, Inc. (NASDAQ: MBII) today announced the results of the previously announced internal investigation conducted by the Audit Committee of its Board of Directors (the “Committee”) regarding certain accounting and other matters.

The Audit Committee Investigation

In September 2014, upon the recommendation of management the Committee commenced an independent investigation concerning certain revenue recognition issues. The Committee’s investigation is now substantially completed.

As part of its investigation, the Committee reviewed certain of the Company’s historical sales transactions with distributors.  The principal findings of the Committee were that (i) certain employees did not share with the Company’s finance department or the external auditors certain important transactional terms, (ii) certain sales personnel executed inaccurate “sales representation” letters, which are intended to inform the Company’s finance department and the external auditors of any commitments not included on a customer purchase order provided to the finance department, and (iii) certain employees mischaracterized expenses related to agreements to pay for the storage and freight fees associated with certain transactions.  As a result, the Committee concluded that the Company recognized revenue for certain transactions prior to satisfying the criteria for revenue recognition required under U.S. Generally Accepted Accounting Principles.  In addition, the Committee found that supply chain personnel were directed to ship the wrong product to a customer because the Company did not have the ordered product readily available.  The employees primarily responsible for the foregoing conduct are no longer with the Company.

The Committee concluded that the Company can rely on current management to accurately prepare the Company’s financial statements.  The Committee also made certain remedial recommendations, which the Company intends to implement promptly.

The San Francisco Regional Office of the United States Securities & Exchange Commission has opened an investigation of this matter, with which the Company has been cooperating fully.

Financial Statement Review

In light of the Committee’s findings, management of the Company is evaluating the necessity, nature and scope of any restatements to any of its previously filed financial statements.  Due to the ongoing nature of this evaluation, the Company cannot at this time provide an estimate of the timing, extent, or effect of any such restatement.

In addition, management is considering the Company’s prior conclusions of the adequacy of its internal control over financial reporting and disclosure controls and procedures, and related material weaknesses in such controls.  The Company intends to amend certain prior disclosures pertaining to its evaluation of such controls and procedures, and material weaknesses, as appropriate in connection with any amended filings, and will consider whether any further remedial measures may be advisable.

NASDAQ Matters

On November 14, 2014, the Company filed with the Commission a Form 12b-25 Notification of Late Filing relating to its Quarterly Report on Form 10-Q for the quarter ended September 30, 2014 (the “Form 10-Q”).  The Company reported in the Form 12b-25 that it was unable to complete the filing pending completion of the Audit Committee’s investigation.

As previously reported, on November 17, 2014, the Company received a letter from The NASDAQ Stock Market LLC (“NASDAQ”) indicating that the Company is not in compliance with the filing requirements for continued listing under NASDAQ Listing Rule 5250(c)(1) as a result of the Company’s delay in filing the Form 10-Q.  In accordance with the requirements set forth in the letter, the Company submitted a plan to regain compliance with NASDAQ’s filing requirements for continued listing on January 16, 2015. On January 27, 2015, the Company received a letter from NASDAQ granting the Company an extension until May 13, 2015 to file any delinquent reports and regain compliance.

*****

About Marrone Bio Innovations

Marrone Bio Innovations, Inc. (NASDAQ: MBII) is a leading provider of bio-based pest management and plant health products for the agriculture, turf and ornamental and water treatment markets. Our effective and environmentally responsible solutions help customers operate more sustainably while controlling pests, improving plant health, and increasing crop yields. We have a proprietary discovery process, a rapid development platform, and a robust pipeline of pest management and plant health product candidates. At Marrone Bio Innovations we are dedicated to pioneering better biopesticides that support a better tomorrow for users around the globe. For more information, please visit www.marronebio.com.

Forward Looking Statements

Portions of this press release may constitute “forward-looking statements,” and assumptions underlying such forward-looking statements, within the meaning of the Private Securities Litigation Reform Act of 1995 (the “PSLRA”), Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. Any such forward-looking statements are made within the “safe-harbor” protections of the PSLRA, should not be relied upon as representing our views as of any subsequent date, and we are under no obligation to, and expressly disclaims any responsibility to, update or alter these forward-looking statements, whether as a result of new information, future events or otherwise. Forward-looking statements in this filing include those regarding: the Company’s implementation of remedial measures recommended by the Audit Committee, the ongoing SEC investigation, the necessity, nature and scope of any restatements to the Company’s  previously filed financial statements, the identification and implementation of remedial measures, results of management’s review of, and amendments to prior disclosures regarding, internal controls over financial reporting and disclosure controls, expectations regarding the timing of the Company’s periodic reports and expectations regaining full compliance with Nasdaq continued listing requirements. Such forward-looking statements are based on information available to us as of the date of this release and involve a number of risks and uncertainties, some beyond our control, that could cause actual results to differ materially from those anticipated by these forward-looking statements. Such risks include uncertainty surrounding management’s ongoing evaluation of any potential restatements to any of the Company’s previously filed financial statements, the types of errors and adjustments that may be required in any such restatement, the extent of any material weaknesses or significant deficiencies in the Company’s internal and disclosure controls, how promptly and thoroughly the recommendations of the Audit Committee can be implemented, potential legal or regulatory action related to the matters under investigation, and adverse decisions by the SEC or NASDAQ. In addition, the Company faces other risks and uncertainties that could affect its ability to complete the restatement of its financial statements, to file its periodic reports, and to regain compliance with the NASDAQ listing requirements. Additional information that could lead to material changes in the Company’s performance is contained in its filings with the Securities and Exchange Commission.

Marrone Bio Innovations’ REGALIA® MAXX Biofungicide Approved For New Uses In Canada

Plant Extract-Based Fungicide Brings Canadian Growers Expanded Solution for Protecting Against Disease, Resulting in Higher Quality Crops and Enhanced Yields

DAVIS, Calif., Jan. 22, 2015 — Marrone Bio Innovations, Inc. (MBI), (Nasdaq:MBII), a leading provider of bio-based pest management and plant health products for the agriculture, turf and ornamental and water treatment markets, today announced that its REGALIA® MAXX biofungicide has received approval for new uses in Canada. REGALIA MAXX is a plant extract-based advanced biofungicide that activates plants’ natural defenses to boost plant vigor, combat fungal and bacterial diseases, and enhance yield potential.

The recently approved new uses for REGALIA MAXX in Canada include outdoor and greenhouse grown ornamental plants, annual and perennial flower plants, greenhouse grown peppers, and outdoor grown highbush blueberries, apples and turf. Health Canada’s Pest Management Regulatory Agency initially approved REGALIA MAXX biofungicide in April 2012 for outdoor and greenhouse use on a variety of fruits and vegetables, as well as on wheat and ornamentals. Brock Puddicombe, Product Manager at Engage Agro “believes that these new uses will continue to help growers remain competitive as they compete in world markets.” REGALIA MAXX, will continue to be distributed exclusively in Canada by Engage Agro, a leading Canadian distributor specializing in high-value fruit and vegetable crops.

“We are pleased that REGALIA MAXX has been approved for new uses in Canada, bringing growers an expanded environmentally responsible and effective solution for managing pests in conventional and organic crops,” said MBI CEO Pam Marrone. “MBI is well-positioned to expand the footprint of REGALIA MAXX in Canada as growers look to strengthen their integrated pest management programs, improve plant health, boost yields and increase profitability.”

“The expanded use label for REGALIA MAXX will provide Ontario greenhouse vegetable producers with a valuable tool for managing powdery mildew on tomatoes and peppers and for downy mildew on cucumber, while apple, blueberry and turf growers gain an additional product to integrate into their disease control programs,” said Jim Chaput, Provincial Minor Use Coordinator for the Ontario Ministry of Agriculture, Food and Rural Affairs.

REGALIA MAXX is the first biopesticide with Induced Systemic Resistance (ISR), a complex mode of action which creates a defense response in the treated plants and stimulates additional biochemical pathways that strengthen the plant structure and act against the pathogen.

REGALIA MAXX is an advanced biofungicide that can minimize chemical residues by being used alone in a disease-control program, particularly for exported crops at the end of the season right before harvest or in rotation with synthetic fungicides or in a tank mix. The product induces a plant’s natural defenses to protect against a variety of fungal and bacterial diseases and features multiple modes of action, which helps to prevent or delay the development of disease resistance. It also provides a minimal for the REI cite re-entry interval that increases operational flexibility and a zero-day post-harvest interval so crop quality can be protected right up to harvest. REGALIA MAXX is proven to suppress diseases such as powdery mildews on cucurbits (melons, cucumber, zucchini), cane berries, tomatoes (including tomatillo), eggplant, peppers, grapes and ornamentals; as well as Alternaria on tomatoes and potatoes.

*****

About Marrone Bio Innovations

Marrone Bio Innovations, Inc. (NASDAQ: MBII) is a leading provider of bio-based pest management and plant health products for the agriculture, turf and ornamental and water treatment markets. Our effective and environmentally responsible solutions help customers operate more sustainably while  suppressing important pests, improving plant health, and increasing crop yields. We have a proprietary discovery process, a rapid development platform, and a robust pipeline of pest management and plant health product candidates. At Marrone Bio Innovations we are dedicated to pioneering better biopesticides that support a better tomorrow for users around the globe. For more information, please visit www.marronebio.com.

Forward Looking Statements

Portions of this press release may constitute “forward-looking statements,” and assumptions underlying such forward-looking statements, within the meaning of the Private Securities Litigation Reform Act of 1995 (the “PSLRA”), Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. Any such forward-looking statements are made within the “safe-harbor” protections of the PSLRA, should not be relied upon as representing our views as of any subsequent date, and we are under no obligation to, and expressly disclaims any responsibility to, update or alter these forward-looking statements, whether as a result of new information, future events or otherwise. Forward-looking statements in this filing include those regarding driving growth, enhancing market leadership and increasing value for shareholders. Such forward-looking statements are based on information available to us as of the date of this release and involve a number of risks and uncertainties, some beyond our control, that could cause actual results to differ materially from those anticipated by these forward-looking statements. Such risks include adverse weather conditions and seasonality that may affect sales, failure of customers to adopt our products, the high level of competition in the market for pest management products, inability to maintain and further establish successful relationships with third-party distributors, the failure of our third-party distributors to sell to end users and uncertainty surrounding the timing and results of the Audit Committee’s independent investigation of accounting matters. Additional information that could lead to material changes in our performance is contained in our filings with the Securities and Exchange Commission.

James Iademarco Joins Marrone Bio Innovations As President And Chief Operating Officer

January 14, 2015, DAVIS, CA — Marrone Bio Innovations, Inc. (MBI), (NASDAQ: MBII), a leading provider of bio-based pest management and plant health products for the agriculture, turf and ornamental and water treatment markets, today announced that James Iademarco has joined the company as its President and Chief Operating Officer. Mr. Iademarco will have responsibility for directing operations of the company, including sales, marketing, manufacturing and corporate infrastructure, with a particular focus on driving sustainable revenue growth.

Pam Marrone, Chief Executive Officer of Marrone Bio Innovations, said, “We are very pleased to have an experienced executive join MBI from the agriculture, industrial fermentation and materials industries to drive excellence throughout our operations. I expect that we will be a powerful team as we continue to implement our growth strategy and sharpen our focus on driving value to our shareholders.”

Most recently, Mr. Iademarco founded and ran Strategic Avalanche, a global consulting firm focused on the agriculture, biotechnology, renewable chemicals and material sectors. Strategic Avalanche enabled sustainable growth and value creation for a range of companies and was tasked to assess operations, refine business models, identify partnerships, structure go-to-market initiatives and raise strategic capital. Prior to founding Avalanche, Mr. Iademarco was Vice President of Integration for Biomedical Materials and Vice President, Biobased Chemicals and Materials for Royal DSM in Europe. Prior to DSM, he was General Manager, Biomaterials, New Business Ventures, for Bayer Crop Science, where he led strategic investments spanning agricultural biotechnology, nutrition and biofuels and led teams to create a new biomaterials platform and to leverage existing agriculture trait technologies. Before Bayer, he was Director of Business Development for Diversa and he held several positions of increasing responsibility at Monsanto Company and Solutia. He started his career at Monsanto in crop protection sales and marketing.

“I am thrilled to join MBI in a key senior leadership position,” said Mr. Iademarco. “We have a great opportunity to develop the most exciting segment of ag inputs — biologicals for pest management and plant health. I am very impressed by MBI’s position in the market, with a number of science-based, effective products already launched, and with a strong and promising pipeline of new products. I look forward to working with the Board, our management team and employees to ensure that we work hard to drive growth, enhance our market leadership position and create sustainable value for our shareholders.”

Elin Miller, MBI’s Chairwoman of the Board, commented, “We are excited to bring on an executive with James’ level of operational expertise. The Board looks forward to working closely with James and Pam to help drive MBI’s value.”

 *****

About Marrone Bio Innovations

Marrone Bio Innovations, Inc. (NASDAQ: MBII) is a leading provider of bio-based pest management and plant health products for the agriculture, turf and ornamental and water treatment markets. Our effective and environmentally responsible solutions help customers operate more sustainably while controlling pests, improving plant health, and increasing crop yields. We have a proprietary discovery process, a rapid development platform, and a robust pipeline of pest management and plant health product candidates. At Marrone Bio Innovations we are dedicated to pioneering better biopesticides that support a better tomorrow for users around the globe. For more information, please visit www.marronebio.com.

Forward Looking Statements

Portions of this press release may constitute “forward-looking statements,” and assumptions underlying such forward-looking statements, within the meaning of the Private Securities Litigation Reform Act of 1995 (the “PSLRA”), Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. Any such forward-looking statements are made within the “safe-harbor” protections of the PSLRA, should not be relied upon as representing our views as of any subsequent date, and we are under no obligation to, and expressly disclaims any responsibility to, update or alter these forward-looking statements, whether as a result of new information, future events or otherwise. Forward-looking statements in this filing include those regarding driving growth, enhancing market leadership and increasing value for shareholders. Such forward-looking statements are based on information available to us as of the date of this release and involve a number of risks and uncertainties, some beyond our control, that could cause actual results to differ materially from those anticipated by these forward-looking statements. Such risks include adverse weather conditions and seasonality that may affect sales, failure of customers to adopt our products, the high level of competition in the market for pest management products, inability to maintain and further establish successful relationships with third-party distributors, the failure of our third-party distributors to sell to end users and uncertainty surrounding the timing and results of the Audit Committee’s independent investigation of accounting matters. Additional information that could lead to material changes in our performance is contained in our filings with the Securities and Exchange Commission.

  1. Pages:
  2. 1
  3. 2
  4. 3
  5. 4
  6. 5
  7. 6
  8. 7
  9. ...
  10. 24